5.48 USD
▼-0.33-5.68%
盘后 6.19 0.00%
2026-09-15
市值
$291.93M
市盈率
—
EPS
-2.89
股息率
—
52 周区间
5.46 – 33.68
成交量
421.16K
Beta
—
目标价
31.14
52W 低 5.4652W 高 33.68
价格走势
公司简介
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.